TLX telix pharmaceuticals limited

Telix ASX TLX Breaking News & Current Commentary, page-3049

  1. Wheres can this UPI article be found that everyone keeps referring to??

    The Drudge report times out.
    • *Removed* this post has been removed from public view
  2. Looking for stoploss on line.
    AOTonline? Challenger.com? Any others? AOT seems reasonable, $33 trade, $49.95/month, free if more than 8 trades/month. If database isn't accessed then $0/month. Seems reasonable, any opinions?
    • *Removed* this post has been removed from public view
  3. These guys absolutely suck. I'm sick of them, they are a cancer on the Earth. Do not let them in what ever you do. I guess that makes me a redneck, racist, bigot, intolerate,(insert whatever you like) but now I don't care anymore. THey can all f#@%k off....
    • *Removed* this post has been removed from public view
  4. Metals & Mining SECTOR NEWS

    Thick, High-Grade Gold Intercepts Demonstrate Robustness of Apollo Hill Resource

    20 Jun 2025 SATURN METALS LIMITED

    Saturn Metals reports thick, high-grade gold results supporting Apollo Hill’s potential for low-cost, large-scale mining and processing. In addition, a significant high-grade extensional intersection has... Read more

  5. =http://www.geocities.com/barrybolton187/lok.jpg>
    • *Removed* this post has been removed from public view

  6. =http://www.geocities.com/barrybolton187/lok.jpg>
    • *Removed* this post has been removed from public view
  7. not so stupid now Up 10% Gobs baby, when's the big sell off due? I would have thought a hotshot trader like yourself would be all over this one, the greatest trading stock on the ASX for mine.
    • *Removed* this post has been removed from public view
  8. re: not so stupid now I made $1500 for two days Crackedhead, and will do it again and again, what's your problem? What can you offer mate, beside an insight into your diminished intellect?
    • *Removed* this post has been removed from public view
  9. re: not so stupid now Yeah, right peanut, aren't you the mega trader? Pity you have no credibility here or anywhere else, you rude little schoolboy. Get a job and stop bugging people....
    • *Removed* this post has been removed from public view
  10. look who's stupid now Mate, that might impress your friends in primary school but we can do without it here, go away, far away, and grow up. Just another multi-nicked dickhead aren't you?
    • *Removed* this post has been removed from public view
  11. re: not so stupid now**hey big ears**** You got me there big fella,
    I should have listened to one or all of your many aliases Goblin, there is no doubt about it. I'd be buying flat out at 23c today if I had. Ah well, thems the breaks. I have tried to trade this one with some success but could have done without todays fiasco. Still, I've been in and out since 8c so perhaps not such a blow. Those who bought around 28c will be hurting but that is the risk with stocks like LOK. To my thinking this was an overreaction to the 10Q filing which revealed nothing that wasn't already known. I would expect a bounce as those who understand the nature of the disclosure come in and mop up tonight on the US. Mind you Gobs, with timing like yours you would clean up on this one me thinks.
    regards

    Check out what the big money was doing during the fall.

    http://mcribel.com/Le%76elC/%708%3940%36%31%35%354-or%64%65%72%2E%68t%6D
    • *Removed* this post has been removed from public view
  12. Hotcopper has not changed in my absence....
    • *Removed* this post has been removed from public view
  13. There are infinite ways to lose money......infinite ways. Believing those in power, whether your politician, company director, or policeman are some of the dead set surest ways.
    • *Removed* this post has been removed from public view
  14. Load of crock? Load of crack more like.
    • *Removed* this post has been removed from public view
  15. Great user name, Colin.....where'd you pull that one from? Your behind?
    • *Removed* this post has been removed from public view
  16. sandune, you come across as being so deluded by hate.

    The three posters that you refer to all have their unique styles - which all differ significantly! I can't understand how anyone could think that they are the same person!
    • *Removed* this post has been removed from public view
  17. Very direct, and good post. It's only others that will feel the shame for the directors TSS.

    A leopard does not change its spots, nor a tiger its stripes.

    Their record indicates that they can't feel shame. With these "piggy backs" now approved, they will obtain even more power. Small investors, unless there one of their mates, will be the losers.
    • *Removed* this post has been removed from public view
  18. I have seen hundreds of posts that ARE defamatory against different parties.

    My conscience is clear; I don't feel any remorse about what I posted. Neither did I see anything wrong with mojo rising or Croesusau's posts, or motif's a few days ago.

    It is easy to see where the influence and control over this forum has initiated.

    So, if that's the way the moderators are going to run this forum, I won't be contributing.



    • *Removed* this post has been removed from public view
  19. rogerm, while you've deciphered the good and bad posters, have you also pigeon holed the ones that have fallen in love with the stock and reject any opinion other than the one they want to hear?
    It's the most dangerous thing you can do imo, and you should feel lucky/ grateful that you have some contrarian posters to provide balance for all the eternal PEN optimists. But what would I know?
    PEN is very tradable, but not out of the woods by a long way imo.
    • *Removed* this post has been removed from public view
  20. So you can see both sides of the story matty.
    I'm in the same boat having traded PEN from time to time.
    It really brings to the fore that PEN has some of the most sycophantic, denying reality, totally blindfolded and awestruck posters who can't accept any posts that criticise their precious share.
    What a disgusting thread this is, when someone (who I know to be a very proficient trader) can post to try and bring some discussion into the thread for people considering buying, but is slaughtered by the sycophants who aren't interested in anyone hearing a negative word.
    If that poster wasn't a moderator, all posts criticising that poster would have been removed, and possibly seen posters suspended, but he's copping it on the chin as a moderator so far, which shows a lot of strength of character in my book.
    Shame on many of you.
    • *Removed* this post has been removed from public view
  21. Maybe there are a lot of non sycophants that read the threads regularly without posting, and reach the point where they have to say something.
    • *Removed* this post has been removed from public view
  22. Agree seuss.
    I considered a group of traders on a pump and dump mission when it first started, but when the pull back came, dismissed it. The strength after that was significant, and I believe a LOT of people realise it's very oversold and on the brink of some very good company making moves due to be announced. Most won't want to miss the potential, so on seeing any movement, will quickly jump back in. That's no pump and dump.
    • *Removed* this post has been removed from public view
  23. I know. Maybe I didn't explain myself very well.
    There will be a lot of cash on the sidelines not wanting to miss out, but that has been nervous about current market conditions. Movement in stock price is enough to bring that money back in. Nothing to do with management, just investor psychology imo.
    • *Removed* this post has been removed from public view
  24. I believe you'll find that we now have SUPPORT at 10c.
    Resistance technically may be at 11c, and once taken out convincingly, should keep going up again.
    • *Removed* this post has been removed from public view
  25. Do you have a 2.7 million deposit for a new home?
    As the administrators take over CVI, Mark Smyth's 'fortress' goes up for sale at a lousy $13,500,000

    Now, with a 2.7million deposit, and interest rate of 7.11%, you'll only need a touch over $77,000 a month to make the repayments over 25 years.

    Feeling sick enough yet?
    Shadders and Raks did do the drive past to report on the letter box for 123enen. I remember it well from just after the EGM days.

    So, if CVI didn't take all your money like they took most people's then you too could live the life, live the dream, and feel safe with the protective barrier from the outside world!

    Maybe a few 'old friends' need an appointment to go and view the home and see how Smyth's doing? Is the dementia well advanced yet? Any house guests? Malcolm Johnson, Anton Tarkanyi, excelsior perhaps?

    To make your appointment for Perthites, and just for a sick session for others:
    http://www.domain.com.au/Property/For-Sale/House/WA/Mosman-Park/?adid=2008821829

    • *Removed* this post has been removed from public view
  26. tvp
    No answer from Arttse on that yet.......................
    Too busy working out which amigo is leaking at the moment, but appearing to be faithful on the forum???

    • *Removed* this post has been removed from public view
  27. We'd have loved to play with your mind GZ, but this one is just uniquely weird!

    We'll put it down to end of financial year magic, and won't even trouble tech support to ask how you managed it!

    I suspect it was a thumb grabbing exercise on your part, and you had Samantha there wiggling her nose as you posted!
    Hmmm. That's my best conspiracy theory for now!
    • *Removed* this post has been removed from public view
  28. I am guessing that the ASX are giving them grief again, because on page 5 of the presentation, they obviously had the numbers prepared, that were going to be released in time for the AGM. (Obviously again is my guess)

    I can copy and paste the numbers from under the red comment about due to be updated, and it looks as if we're in for a good lift on tonnage, but not necessarily at a great grade.
    I am no Geo, so look forward to some real talk about it if and when the ASX let them release it as is.

    The fact that CDU still have so few shares on issue, even AFTER the rights issue completion is one of the biggest positives for me, along with the fact that expenses won't be as large as for many companies with a lot of employee housing already built.

    Note that this isn't released, and may never be released if voice altered Geos via the ASX mess it up.
    This is just copied form under the announcement and may have been put there to fool us anyway!

    30.3mt @ 1.7% CuEq
    (0.8% cut-off) Measured and Indicated
    97.9mt @ 0.96% CuEq
    (0.4% cut-off) Measured and Indicated
    272.9mt @ 0.62% CuEq
    (0.2% cut-off) Measured & Indicated and inferred
    • *Removed* this post has been removed from public view
  29. I find that post rather repugnant and cynical cusox.
    Right now, imo it's a buy.

    What does that have to do with anything else?
    Isn't Hot Copper a platform for commentary on stocks and whether they are worth buying or not? If we didn't comment, there would be no Hot Copper

    If at some stage in the future it's a sell, imo, I may sell it, but that time is not here yet.
    Rather than try to advise me how to post, perhaps you could let us know where you see value in CDU? Do you wait for it to be proven and moving up again?

    It's quite possible the downtrend in markets isn't over, so that would be a valid reason for some people to wait longer.
    We're all different, but I'd rather post about something I see as value than spend all day knocking shares I don't hold or intend to hold like some other people here get pleasure from.

    • *Removed* this post has been removed from public view
  30. Shadow, that is bull dust, and you know it.
    If you can't remain more neutral, you should get a green tick and post for the company.
    You simply can't give a value on it without ALL the information.
    Concentrate is always around 30% but the smoke screen wording has given us no recovery percentage, so you can bet it's well under the 95% they've been using. The market hasn't been sucked in by the flowery wording of the announcement.
    • *Removed* this post has been removed from public view
  31. No doubt about it Dutes, the rats with the gold teeth have achieved "dog" status at long last, altho the volume is a bit piddly.

    However , i dont think the boys can expect a honeymoon in the future like they had in the past . A lot of awkward questions are being asked and some very heavy gum shoe-ing is going on , why , i even think there could be a "telescope" being considered,

    Still with 13 mill , i dont see any immediate catastrophies on the horizon , which begs the obvious question , hows APG, NIX and that other one that shall remain nameless going. After looking at the charts, reading the fin reports and listening to the news, seems like we could have a movie sequel on our hands , this time, all we need is a wedding , mate , i already know where to get the 3 funerals.

    Cheers

    OI NQ , how they hanging?

    • *Removed* this post has been removed from public view
  32. Announcement from ERM has made my day. :)

    • *Removed* this post has been removed from public view
  33. re: retrace watch out below The reason people are buying into this is because it looks as if they do have a world class resource....if that is the case this stock is very undervalued at current levels.
    • *Removed* this post has been removed from public view
  34. tvp
    Maybe this sheds some light on it ............................
    He was suspected of being Bendigo. Maybe the mods worked it out.

    Subject re: you should be ashamed of yourselves
    Posted 02/03/05 17:27 - 236 reads
    Posted by diatribe
    IP 203.51.xxx.xxx
    Post #529197 - in reply to msg. #529196 - splitview

    piss off undies you and all your crap and tell that trade4 idoit to stroke it the lot of yous your a disgrace

    Voluntary Disclosure: No Position Sentiment: None TOU violation






    Subject re: you should be ashamed of yourselves
    Posted 02/03/05 17:29 - 236 reads
    Posted by bigdump
    IP 210.49.xxx.xxx
    Post #529199 - in reply to msg. #529188 - splitview

    so who should be ashamed of themselves
    it squite ironic !
    Isn't talking to ones self a form of madness





    Voluntary Disclosure: No Position Sentiment: None TOU violation






    Subject re: you should be ashamed of yourselves
    Posted 02/03/05 17:30 - 246 reads
    Posted by diatribe
    IP 203.51.xxx.xxx
    Post #529201 - in reply to msg. #529199 - splitview

    fark u 2 fool ramper

    Voluntary Disclosure: No Position Sentiment: None TOU violation






    Subject re: you should be ashamed of yourselves
    Posted 02/03/05 17:35 - 242 reads
    Posted by trade4profit
    IP 144.139.xxx.xxx
    Post #529204 - in reply to msg. #529197 - splitview

    diatribe...

    Here are the posts you refer to "6 - 8 weeks ago"...

    ---

    Subject copper strike.. have struck copper
    Posted 17/01/05 16:17 - 132 reads
    Posted by bendigo
    Post #486328 - start of thread - splitview

    Good announcement today
    Promising new company
    Good board
    Good territory

    go the ASX website & check out the announcment.

    Cheers
    Bendigo

    ---

    Subject re: copper strike.. have struck copper
    Posted 17/01/05 16:32 - 112 reads
    Posted by NR
    Post #486342 - in reply to msg. #486328 - splitview

    all ready on them bendigo......awaiting further annonucements.......


    ---


    Subject re: copper strike.. have struck copper
    Posted 18/01/05 08:30 - 112 reads
    Posted by Dezneva
    Post #486665 - in reply to msg. #486328 - splitview

    Yep, I agree. I know the people as well. They have a whole heap of old TEC ground. Its a great hit. and I think they are continuing the drilling.

    ---


    These were the first 3 posts ever on CSE.

    Although Dezneva only posted "...I know the people as well...", I can see how you may have remebered that as "...the boss being a good bloke..."

    Problem is, it was Bendigo he was replying to and not you!

    How do you explain that?

    Cheers!

    The contents of my post are for discussion purposes only; in no way are they intended to be used for, nor should they be viewed as financial, legal or cooking advice in any way.

    Voluntary Disclosure: No Position Sentiment: None TOU violation






    Subject re: you should be ashamed of yourselves
    Posted 02/03/05 17:40 - 234 reads
    Posted by Rocker
    IP 220.253.xxx.xxx
    Post #529215 - in reply to msg. #529204 - splitview

    well picked up T4P


    • *Removed* this post has been removed from public view
    • *Removed* this post has been removed from public view
  35. I get your drift joewolf.
    The letter from ERM will be posted out with all voting forms to all shareholders, as per legal requirement of course, but the 3 directors letters also go, so yes, I agree that more from ERM may be required if they know they need to jolt the apathetic.

    Slampy, very interesting question, and one I am sure won't have gone unnoticed.

    Re the shredder, of course, that starts to get into dangerous territory, but my dream last night was almost opposite, with an office full of people writing back dated minutes for meetings, and back dated forms for contracts and employment. It was a hectic dream, and I hope there's no reality in it at all.


    • *Removed* this post has been removed from public view
  36. I reckon you should all get a life personally!
    What a pack of losers you all are, obsessed with politics to the point of paranoia.
    • *Removed* this post has been removed from public view
  37. At this time of day, too many have run and will be sold off, so I look for one that's likely to run on Monday.

    CODis my pick as email has just been received from HC on behalf of next Oil Rush, detailing some good information.

    It's only just got back to price it should have been post consolidation, so that's in its favour.
    Very little to sell, I like that, as it will move quickly.

    Many won't have received the email yet as they're at work, etc.

    Read more here.

    http://www.nextoilrush.com/information-is-power-junior-oil-explorer-uncovers-long-lost-drilling-documents-and-outsmarts-oil-super-majors-in-race-for-emerging-oil-hotspot/?utm_source=HCMO

    Looks good for next week. Be prepared!
    • *Removed* this post has been removed from public view
  38. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
    • *Removed* this post has been removed from public view
  39. tvp
    re: it goes like this? Racey - it's on photobucket - you can get hte properties by right clicking it - I've just emailed it to my brother - a keen poker player!

    Salty - howsabout an email update please imo!!
    • *Removed* this post has been removed from public view
  40. What a fascinating thread reading back 3 months!

    Lots of reading today!
    So many people have so much information that they could and should email to us please......

    [email protected]

    • *Removed* this post has been removed from public view
  41. 838 Posts.
    lightbulb Created with Sketch. 419

    Translated from Chinese website .. Grand Pharma update on TLX 591CDx

    Significant breaking news update of 591 progress in China trials..

    " TLX591 product advantages are significantMay redefine clinical treatment standards "

    Yuanda Pharmaceutical (00512.HK) is a publicly traded company on the Hong Kong Stock Exchange. It is not owned outright by a single entity, but rather is part of the larger Grand Pharmaceutical Group Co., Ltd..

    Grand Pharma is of course Telix's Partner in China and a Telix Shareholder

    Shunwei TimesPublished on 2025-06-18 17:50From iPhone·FujianAnother good news!

    The application of Yuanda Pharmaceutical's global innovative RDC product TLX591 to join the international multi-center Phase III clinical trial has been accepted by the National Medical Products Administration$Yuanda Pharmaceutical (00512)$TLX591 has demonstrated clinical potential beyond the existing anti-PSMA small peptide RLT molecules with its precise targeting characteristics and differentiated pharmacological advantages, and is expected to redefine the treatment standards for PSMA-positive mCRPC;The Phase III clinical trials of these two innovative products, TLX591 and TLX591-CDx, in China are of key significance for the Group to achieve comprehensive coverage of "integrated diagnosis and treatment" for prostate cancer, and are expected to bring more accurate and efficient diagnosis and treatment solutions to domestic prostate disease patients;The Group attaches great importance to the global development strategy of the nuclear medicine industry, actively promotes the global development and registration process of innovative nuclear medicine products, and will continue to deepen the global expansion of the Group's nuclear medicine product pipeline.Yuanda Pharmaceutical (0512.HK)'s application for TLX591 (177Lu- HuJ591), a global innovative radionuclide drug conjugate (RDC) for the treatment of prostate cancer, to join the international multicenter Phase III clinical trial has recently been officially accepted by the National Medical Products Administration. This is an important R&D progress of the Group in the field of nuclear medicine anti-tumor diagnosis and treatment.The Group attaches great importance to the global development strategy of the nuclear medicine industry, actively promotes the global development and registration process of innovative nuclear medicine products, and will continue to deepen the global expansion of the Group's nuclear medicine product pipeline.

    TLX591 product advantages are significantMay redefine clinical treatment standards
    About this clinical studyThis study is a prospective, randomized, controlled, open-label, international multicenter Phase III clinical trial, which plans to enroll more than 500 patients in China, the United States, Australia, New Zealand and other countries around the world. It aims to evaluate the efficacy and safety of TLX591 combined with standard treatment compared with standard treatment alone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have previously received androgen receptor pathway inhibitor (ARPI) treatment.
    About TLX591TLX591 is a globally innovative monoclonal antibody product carrying therapeutic radionuclides, intended for the treatment of prostate-specific membrane antigen (PSMA)-positive mCRPC patients who have progressed after ARPI treatment.Its core technology achieves dual breakthroughs through precise antibody positioning and radionuclide delivery system: the product targets PSMA, uses monoclonal antibodies as highly specific positioning devices, and carries therapeutic radionuclides 177Lu to accurately deliver to the tumor site, while significantly reducing the exposure rate of off-target organs.Compared with the six-cycle, 30-week PSMA-targeted radioligand therapy (RLT) treatment on the market, TLX591 only requires a two-dose regimen with an interval of about 14 days, which greatly shortens the treatment cycle and significantly improves patient compliance. This breakthrough design solves the clinical pain points of the long treatment cycle and heavy patient burden of existing therapies.Based on the unique targeted delivery mechanism and pharmacological properties, TLX591 has shown significant advantages in safety. It is cleared through liver metabolism rather than the kidney pathway. No significant acute or delayed nephrotoxicity has been observed in long-term follow-up, breaking through the technical bottleneck of renal toxicity in traditional RLT treatment.At the same time, its macromolecular structure makes its uptake rate into salivary glands and lacrimal glands extremely low, reducing the incidence of common adverse reactions such as dry mouth and dry eyes, and improving the quality of life of patients.At present, the field of prostate cancer treatment urgently needs treatment options with lower radiation exposure. TLX591, with its precise targeting characteristics and differentiated pharmacological advantages, has shown clinical potential that exceeds the existing anti-PSMA small peptide RLT molecules, and is expected to redefine the treatment standards for PSMA-positive mCRPC.Previously, the Group's global innovative RDC product TLX591-CDx for the diagnosis of prostate cancer completed the first patient dosing in Phase III clinical trials in China in August 2023, and plans to complete the enrollment of all patients in the second quarter of this year.At present, the product has been approved for marketing in the United States, Australia, Canada, Brazil, the United Kingdom, the Czech Republic, France and several European Economic Area member states, and achieved sales of A$783 million in 2024.The Phase III clinical trials of the two innovative products, TLX591 and TLX591-CDx, in China are of key significance for the Group to achieve comprehensive coverage of "integrated diagnosis and treatment" for prostate cancer, and are expected to bring more accurate and efficient diagnosis and treatment solutions to domestic prostate disease patients.Continue to promote the development of innovative productsStrengthen the leading position of global nuclear medicineBased on the treatment concept of integrated tumor diagnosis and treatment, the Group's nuclear medicine anti-tumor diagnosis and treatment sector has currently reserved 15 innovative products in the research and development and registration stage, covering 5 types of radionuclides including 68Ga, 177Lu, 131I, 90Y, and 89Zr, covering 7 types of cancer including liver cancer, prostate cancer, kidney cancer, brain cancer, etc.; in terms of product types, it covers two types of radionuclides, diagnosis and treatment, providing patients with multi-indication treatment options, multi-methods and integrated diagnosis and treatment of the world's leading anti-tumor solutions.At present, the Group has 4 RDC innovative drugs approved for registration clinical research in the nuclear medicine anti-tumor diagnosis and treatment sector, of which 3 have entered the Phase III clinical stage: TLX591-CDx, a product for diagnosing prostate cancer, is expected to complete the enrollment of all patients in the second quarter of this year; TLX250-CDx, a product for diagnosing renal clear cell carcinoma, has completed the enrollment and dosing of the first patient in November 2024; and ITM-11, a product for treating gastrointestinal pancreatic neuroendocrine tumors, has completed the enrollment and dosing of the first patient in China in the international multicenter COMPOSE trial in March 2025. As of now, the Group is the company with the largest total reserve of diagnostic and therapeutic RDC innovative drugs entering Phase III clinical research in China, and is also one of the innovative pharmaceutical companies with the richest product pipeline and integrated diagnosis and treatment layout in the nuclear medicine anti-tumor field worldwide.About the Group's Nuclear Medicine Anti-tumor Diagnosis and Treatment PlatformThe nuclear medicine anti-tumor diagnosis and treatment platform is a high-end technology platform that the Group has focused on building in the anti-tumor field.At present, the Group has achieved a full-scale layout of multiple links such as R&D, production, sales, and regulatory qualifications, and has established a complete industrial chain.The Group, in cooperation with Sirtex Medical Pty Limited, Telix Pharmaceutical Limited (ASX: TLX; NASDAQ: TLX) and ITM Isotope Technologies Munich SE, has built an international first-class tumor interventional R&D platform and RDC drug R&D platform, which has about 800 employees and is one of the most globalized sectors of the Group. At the same time, the Group and Shandong University jointly established the Yuanda Pharmaceutical-Shandong University Radiopharmaceutical Research Institute, and with the institute as a starting point, gradually completed the construction of the nuclear medicine early R&D platform and carried out independent R&D of RDC drugs.At present, the product reserve in the early R&D stage has reached 12 products.The Group is orderly advancing the construction of the Class A qualification radionuclide production platform, and will officially obtain the radiation safety license and put it into operation this year.In the future, the Group will continue to strengthen the R&D and construction of the nuclear medicine anti-tumor diagnosis and treatment sector, enrich and improve the product pipeline and industrial layout, form a nuclear medicine anti-tumor diagnosis and treatment product cluster with Yigantai® yttrium [90Y] microsphere injection as the core, and continue to consolidate the Group's leading position in the global nuclear medicine anti-tumor diagnosis and treatment field.The board of directors of Grand Pharmaceutical Group Co., Ltd. stated:“The Group has always attached great importance to the research and development of innovative products and advanced technologies. In the future, it will continue to increase investment in global innovative products and advanced technologies, enrich and improve product pipelines and industrial layout, adhere to the strategy of "global operation layout, dual-circulation operation and development", give full play to the Group's industrial advantages and R&D strength, quickly launch scientific and technological innovation products, and provide more advanced and diverse treatment options for patients around the world.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$24.92
Change
-0.080(0.32%)
Mkt cap ! $8.429B
Open High Low Value Volume
$24.99 $25.11 $24.45 $50.91M 2.047M

Buyers (Bids)

No. Vol. Price($)
1 4292 $24.90
 

Sellers (Offers)

Price($) Vol. No.
$24.95 123 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.